| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.14 | 0.4 |